Discontinuation report STREPTOMYCIN FOR INJECTION USP
Report ID | 254712 |
Drug Identification Number | 02243660 |
Brand name | STREPTOMYCIN FOR INJECTION USP |
Common or Proper name | STREPTOMYCIN FOR INJECTION USP |
Company Name | STERIMAX INC |
Market Status | MARKETED |
Active Ingredient(s) | STREPTOMYCIN |
Strength(s) | 1G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 1 VIAL |
ATC code | J01GA |
ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2026-04-30 |
Actual discontinuation date | |
Remaining supply date | 2026-04-30 |
Discontinuation status | To be discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Limited inventory remains at McKesson. The expiry date on the remaining stock is April 30, 2026. |
Company comments | Inventory has been depleted at SteriMax. Limited inventory remains at McKesson. Product will be discontinued upon depletion of the remaining inventory. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2025-04-10 | French | Compare |
v1 | 2025-04-10 | English | Compare |
Showing 1 to 2 of 2